Literature DB >> 10679126

Accumulation of common T cell clonotypes in the salivary glands of patients with human T lymphotropic virus type I-associated and idiopathic Sjögren's syndrome.

M Sasaki1, S Nakamura, Y Ohyama, M Shinohara, I Ezaki, H Hara, T Kadena, K Kishihara, K Yamamoto, K Nomoto, K Shirasuna.   

Abstract

To clarify the pathogenesis of human T lymphotropic virus type I (HTLV-I)-associated Sjögren's syndrome (SS), the TCR Vbeta gene usage by the infiltrating lymphocytes in the target organ was examined. The Vbeta families predominantly used in the labial salivary gland (LSG) from the HTLV-I-seropositive (HTLV-I+) SS patients were more restricted than those from the HTLV-I-seronegative (idiopathic) SS patients, and were commonly Vbeta5.2, Vbeta6, and Vbeta7. The single-strand conformation polymorphism analysis revealed that T cell clonotypes with Vbeta5.2, Vbeta6, and Vbeta7 accumulate in the LSG from the HTLV-I+ and idiopathic SS patients. Among junctional sequences of the most dominant Vbeta7 transcripts, the conserved amino acid motif (QDXG: X is any amino acid) was found in six of the five HTLV-I+ SS patients and was also detected in two of the five idiopathic SS patients. Using the probes specific to the motif, the Vbeta7 transcripts with the motif were detected in the LSG from all of the seven HTLV-I+ and five of the six idiopathic SS patients, but not from eight healthy subjects. The Vbeta7 transcripts with this motif were also detected in the HTLV-I-infected T cell lines obtained from the LSG of an HTLV-I+ SS patient. The accumulation of HTLV-I-infected T cells expressing TCR with the conserved motif was thus indicated. These T cells were commonly present in patients with idiopathic SS and are strongly suggested to most likely be involved in the pathogenesis of both HTLV-I-associated and idiopathic SS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679126     DOI: 10.4049/jimmunol.164.5.2823

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Single-cell analysis of glandular T cell receptors in Sjögren's syndrome.

Authors:  Michelle L Joachims; Kerry M Leehan; Christina Lawrence; Richard C Pelikan; Jacen S Moore; Zijian Pan; Astrid Rasmussen; Lida Radfar; David M Lewis; Kiely M Grundahl; Jennifer A Kelly; Graham B Wiley; Mikhail Shugay; Dmitriy M Chudakov; Christopher J Lessard; Donald U Stone; R Hal Scofield; Courtney G Montgomery; Kathy L Sivils; Linda F Thompson; A Darise Farris
Journal:  JCI Insight       Date:  2016-06-02

Review 2.  Is Sjögren's syndrome a retroviral disease?

Authors:  Nikolaos V Sipsas; Maria N Gamaletsou; Haralampos M Moutsopoulos
Journal:  Arthritis Res Ther       Date:  2011-04-13       Impact factor: 5.156

3.  Salivary anti-Ro60 and anti-Ro52 antibody profiles to diagnose Sjogren's Syndrome.

Authors:  K H Ching; P D Burbelo; M Gonzalez-Begne; M E P Roberts; A Coca; I Sanz; M J Iadarola
Journal:  J Dent Res       Date:  2011-01-06       Impact factor: 6.116

4.  Lamivudine is not effective in primary Sjögren's syndrome.

Authors:  B Gescuk; A J Wu; J P Whitcher; T E Daniels; S Lund; K Fye; J C Davis
Journal:  Ann Rheum Dis       Date:  2005-02-11       Impact factor: 19.103

Review 5.  Autoimmunity and infection in Sjögren's syndrome.

Authors:  Ann Igoe; R Hal Scofield
Journal:  Curr Opin Rheumatol       Date:  2013-07       Impact factor: 5.006

6.  Selective localization of T helper subsets in labial salivary glands from primary Sjögren's syndrome patients.

Authors:  T Maehara; M Moriyama; J-N Hayashida; A Tanaka; S Shinozaki; Y Kubo; K Matsumura; S Nakamura
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

7.  Cytokine/chemokine profiles contribute to understanding the pathogenesis and diagnosis of primary Sjögren's syndrome.

Authors:  M Moriyama; J-N Hayashida; T Toyoshima; Y Ohyama; S Shinozaki; A Tanaka; T Maehara; S Nakamura
Journal:  Clin Exp Immunol       Date:  2012-07       Impact factor: 4.330

8.  Increased proviral load in HTLV-1-infected patients with rheumatoid arthritis or connective tissue disease.

Authors:  Maria Yakova; Agnès Lézin; Fabienne Dantin; Gisèle Lagathu; Stéphane Olindo; Georges Jean-Baptiste; Serge Arfi; Raymond Césaire
Journal:  Retrovirology       Date:  2005-02-01       Impact factor: 4.602

9.  Beyond the Glands: An in-Depth Perspective of Neurological Manifestations in Sjögren's Syndrome.

Authors:  Alexandria Voigt; Sukesh Sukumaran; Cuong Q Nguyen
Journal:  Rheumatology (Sunnyvale)       Date:  2014

Review 10.  Role of Viral Infections in the Pathogenesis of Sjögren's Syndrome: Different Characteristics of Epstein-Barr Virus and HTLV-1.

Authors:  Hideki Nakamura; Toshimasa Shimizu; Atsushi Kawakami
Journal:  J Clin Med       Date:  2020-05-13       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.